Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/5/2025

Treatment of Symptomatic Premature Atrial Contractions with Low Ectopy Burden

Initial Evaluation and Reversible Causes

  • The American College of Cardiology recommends checking and correcting potassium and magnesium deficiencies, as these are common reversible triggers for symptomatic PACs with low ectopy burden 1
  • The American Heart Association suggests screening thyroid function, as hyperthyroidism is a potentially reversible cause requiring specific treatment for symptomatic PACs with low ectopy burden 1
  • The American College of Cardiology advises assessing and reducing caffeine intake, medications, and other stimulants to address stimulant exposure in patients with symptomatic PACs with low ectopy burden 1
  • Evaluating for sleep-disordered breathing as a contributing factor is recommended for patients with symptomatic PACs with low ectopy burden 1
  • Reducing or eliminating alcohol intake is suggested for patients with symptomatic PACs with low ectopy burden 1

Pharmacologic Treatment Algorithm

First-Line Therapy

  • Beta blockers are the preferred initial pharmacologic treatment for symptomatic PACs, offering both symptom control and potential prevention of progression to atrial fibrillation, according to the American College of Cardiology 1

Second-Line Options

  • Sotalol can be considered for patients with severe symptoms despite first-line therapy, providing both rate control and PAC suppression, as recommended by the American Heart Association 1
  • Amiodarone may be used in patients with structural heart disease, though this is typically reserved for more refractory cases, according to the American College of Cardiology 1

Important Contraindications

  • Class IC antiarrhythmics (flecainide, propafenone) should be avoided in patients with any structural heart disease due to increased proarrhythmic risk, as advised by the American Heart Association 1
  • Digoxin should never be used in patients with pre-excitation syndromes like Wolff-Parkinson-White, as it may dangerously accelerate ventricular rates, according to the American College of Cardiology 1

Monitoring and Long-Term Considerations

  • Patients with frequent PACs should be monitored for development of atrial fibrillation, as they represent a high-risk group, according to the American Heart Association 1
  • If atrial fibrillation develops, assessing stroke risk using the CHA₂DS₂-VASc score and considering anticoagulation accordingly is recommended by the American College of Cardiology 1

Perioperative Context

  • In perioperative settings, beta blockers have demonstrated effectiveness in reducing arrhythmia incidence, as reported by the Journal of the American College of Cardiology 2, Circulation 3, and the Journal of the American College of Cardiology 4

REFERENCES

1

Management of Runs of Premature Atrial Contractions (PACs) [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025